» Articles » PMID: 30804487

Combined Use of Ruxolitinib and Sirolimus: Increased Monitoring of Triglycerides Required

Overview
Specialty General Surgery
Date 2019 Feb 27
PMID 30804487
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Rapid Resolution of Life-Threatening Hypertriglyceridemia after Evinacumab Administration in a Pediatric HSCT Recipient: A Case Report.

Fachin A, De Carlo C, Maestro A, Zanon D, Barbi E, Maximova N Pharmaceuticals (Basel). 2023; 16(8).

PMID: 37630982 PMC: 10457918. DOI: 10.3390/ph16081069.


Commentary: Longitudinal changes in circulating metabolites and lipoproteins after breast cancer treatment.

Guha A, Stabellini N, Montero A Front Cardiovasc Med. 2022; 9:962698.

PMID: 36017091 PMC: 9395698. DOI: 10.3389/fcvm.2022.962698.


Haematological Drugs Affecting Lipid Metabolism and Vascular Health.

Parrella A, Iannuzzi A, Annunziata M, Covetti G, Cavallaro R, Aliberti E Biomedicines. 2022; 10(8).

PMID: 36009482 PMC: 9405726. DOI: 10.3390/biomedicines10081935.


Etiology and Management of Dyslipidemia in Patients With Cancer.

de Jesus M, Mohammed T, Singh M, Tiu J, Kim A Front Cardiovasc Med. 2022; 9:892335.

PMID: 35548413 PMC: 9081373. DOI: 10.3389/fcvm.2022.892335.